# MetLife: how the business works

> For learning only. Cityfort is not a registered investment adviser or broker-dealer and does not recommend buying or selling any security. Prices shown are dated and may be out of date.

MetLife, Inc. · NYSE: MET · Sector: Financials

Updated for Q3 FY2026 · checked Nov 20, 2026

This is the plain-text version of https://cityfort.co/stocks/metlife. Source ids in [brackets] refer to the list at the end. Credit: "Cityfort, MetLife: how the business works", with the page URL.

## The 30-second summary

MetLife sells workplace benefits, life insurance and pension risk transfers in the U.S., Asia, Latin America and Europe and the Middle East. It collects premiums ($49,779M in FY2025), invests the money and pays claims later. Of every $100 that came in during FY2025, $4.0 was left as net income for common shareholders. That net income of $3,173M came after $3,084M of investment and derivative losses, while the company's own adjusted earnings measure was $5,943M.

## 5 points

- **What it sells:** MetLife sells workplace benefits, life insurance, pension risk transfers and annuities in the U.S. and abroad, and its asset management arm had $741.7B of assets under management at Dec 31, 2025. [S4, S19]
- **Who pays it:** In FY2025, Group Benefits (U.S. employers) brought in 37.2% of segment revenue, Retirement and Income Solutions 29.1%, Asia 16.5%, Latin America 11.5%, EMEA 4.4% and MetLife Investment Management 1.3%. [S4]
- **What it keeps from $100:** Of every $100 that came in during FY2025, MetLife spent $61.2 on claims and benefits and kept $4.0 as net income for common shareholders, after $3.8 of investment and derivative losses; its own operating measure, adjusted earnings available to common shareholders, was $5,943 million. [S4]
- **Where the operating profit comes from:** In FY2025, adjusted earnings were $1,702 million in Asia, $1,692 million in Group Benefits, $1,671 million in Retirement and Income Solutions and $798 million in Latin America, while Corporate & Other lost $293 million. [S4]
- **The one thing to watch:** Book value per share (stockholders' equity for each share) was $30.73 at Sep 30, 2026, against $39.52 a year earlier, and gross unrealized losses on its bonds were $43.9 billion. [S17, S1]

## What does MetLife sell?

MetLife sells life insurance, workplace benefits and retirement income products. It also manages money for pension funds and other big investors.

- **Workplace benefits (Group Benefits):** Life, dental, disability, accident, vision and pet cover that U.S. employers buy for their staff, sold mostly through MetLife's own employees and brokers. [S4]
- **Retirement and income products (RIS):** Pension risk transfers, where MetLife takes over a company's pension payments for a lump sum. It also sells stable value funds, income annuities and structured settlements in the U.S., and longevity reinsurance (cover against people living longer than expected) in the U.K. [S4]
- **Insurance outside the U.S.:** Life, accident and health, and savings products in Asia (Japan is the largest of nine markets), Latin America (Mexico and Chile are the largest) and Europe and the Middle East. [S4]
- **Asset management (MIM):** MetLife Investment Management runs bond, real estate, private credit and other funds for outside institutions, and manages MetLife's own investments. [S4]

## Who pays MetLife?

- **U.S. employers:** Buy group life, dental and disability cover for their workers; Group Benefits had $26,881M of segment revenue in FY2025. [S4]
- **Pension plans and institutions:** Pay MetLife to take over pension payments or to hold stable value and annuity products; RIS had $21,036M of segment revenue in FY2025. [S4]
- **Families and individuals abroad:** Buy life, health and savings policies in Asia, Latin America and Europe and the Middle East through agents, banks and direct sales. [S4]
- **Institutional investors:** Pay fees to MetLife Investment Management to run their money. [S4]
- **Customer concentration:** The FY2025 10-K says no single customer exceeded 10% of premiums, fees and other revenues in 2025, 2024 or 2023. [S4]

## Where the money went (FY2025)

1. Employers, pension plans and individuals paid $49,779M of premiums in FY2025.
2. MetLife invests the money it holds; those investments earned $22,559M.
3. Fees on savings-type policies and other revenues added $7,830M.
4. Claims, benefits and interest credited to policyholders took most of the money.
5. Running costs, investment losses, tax and preferred dividends took most of the rest, leaving $3,173M of net income for common shareholders.

Sources: S4.

## Key numbers by year (US$ million)

Financials: consolidated, US$ million. Fiscal years are the company's own: Fiscal year ends Dec 31 (the calendar year). — = not shown on the page.

| Year | Revenue | EBITDA | EBITDA margin | Net profit | Net margin | EPS (US$ per share, diluted) | Operating cash flow | Capital spending | Free cash flow | Sources |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| FY2021 (restated) | 68,696 | — | — | 6,654 | 9.7% | 7.65 | 12,347 | — | — | S12, S14 |
| FY2022 (restated) | 68,770 | — | — | 5,099 | 7.4% | 6.3 | 13,044 | — | — | S8, S13, S12 |
| FY2023 | 66,905 | — | — | 1,380 | 2.1% | 1.81 | 13,721 | — | — | S12 |
| FY2024 | 70,986 | — | — | 4,226 | 6.0% | 5.94 | 14,598 | — | — | S8, S4 |
| FY2025 | 77,084 | — | — | 3,173 | 4.1% | 4.71 | 17,092 | — | — | S4 |

- EBITDA here = operating income plus depreciation and amortization (from the cash flow statement).
- Net profit is the share belonging to the company's owners.
- For an insurer, revenue is total revenue including premiums and investment income, as on the page.

## Who owns MetLife? (as of Mar 31, 2026)

No single owner controls MetLife; the policyholder trust is the largest holder. The 10-K says the board can influence stockholder votes through the trust's voting rules. Directors and executive officers as a group held 2,575,534 shares, 0.4% (Cityfort calculation from the 2026 proxy statement: shares ÷ 647,046,202 outstanding at Mar 31, 2026). [S15, S4, S1]

- Officers and directors (as a group), shares: 0.4%

| Class | Shares (millions) | Votes per share | % of shares | % of votes | Traded | Sources |
| --- | --- | --- | --- | --- | --- | --- |
| Common stock (628,442,143 shares outstanding at Oct 30, 2026, from the Q3 FY2026 10-Q cover.) | 628.4 | 1 | — | — | Yes | S1 |

Holders of 5% or more (each row shows the date of its own filing):

| Holder | Shares | Votes | As of | Note | Sources |
| --- | --- | --- | --- | --- | --- |
| Beneficiaries of the MetLife Policyholder Trust | 16.17% | — | Mar 31, 2026 | 104,607,712 shares held of record by the trust (trustee Wilmington Trust), as listed in the 2026 proxy statement. | S15 |
| Dodge & Cox | 8.26% | — | Feb 13, 2024 | 53,443,191 shares, from a Schedule 13G/A filed Feb 13, 2024, as quoted in the 2026 proxy statement. | S15 |
| BlackRock, Inc. | 8.15% | — | Jan 26, 2024 | 52,733,080 shares, from a Schedule 13G/A filed Jan 26, 2024, as quoted in the 2026 proxy statement. | S15 |

## What could go wrong

### Interest rates move book value

Book value per share fell to $30.73 at Sep 30, 2026 from $39.52 a year earlier, as accumulated other comprehensive loss (gains and losses kept out of net income, such as paper losses on bonds) grew to $25,304M. The 10-Q says gross unrealized losses on bonds rose to $43.9 billion, mainly because interest rates rose. [S17, S1]

What to watch: Book value per share and accumulated other comprehensive loss in each quarter's 10-Q.

### Losses on investments

MetLife held $315,931M of bonds and $84,593M of mortgage loans at Dec 31, 2025; 4.0% of its rated bonds were below investment grade (the riskier rating grades). The 10-K lists defaults and downgrades of its investments as a risk. [S4]

What to watch: Net investment losses and the below-investment-grade share.

### Claims can exceed estimates

Prices and reserves rest on assumptions about deaths, illness and lifespans. Its 2026 annual assumption review lowered Q3 FY2026 adjusted earnings by $46M. [S4, S23]

What to watch: Group life mortality ratio in the quarterly supplement.

### Lumpy pension deals

Pension risk transfer premiums arrive in large, uneven amounts: premiums were $16,691M in Q4 FY2025 against $10,555M in Q3 FY2025. [S17]

What to watch: RIS premiums, fees and other revenues excluding pension risk transfers.

### Ratings drive sales

The 10-K says a downgrade, or a possible one, of its financial strength or credit ratings could cost it business and raise its cost of capital. [S4]

What to watch: Rating agency actions on Metropolitan Life Insurance Company.

### Reinsurance partner exposure

MetLife had receivables of $11.9 billion related to Chariot Reinsurance, a related party, at Sep 30, 2026. Against that it had a funds withheld liability of $12.3 billion: assets MetLife keeps but owes to Chariot under the reinsurance deal. [S1]

What to watch: Related-party note in each 10-Q.

### Rules and taxes

The 10-K lists changes in insurance laws, supervision and tax rules as risks that could reduce profit or make its products less attractive to buyers. [S4]

What to watch: Regulatory changes named in the 10-K and 10-Qs.

### Trust shares and takeovers

The 10-K says the board may influence stockholder votes through the MetLife Policyholder Trust, which held 16.17% of shares at Mar 31, 2026. [S4, S15]

What to watch: The trust's share count in the yearly proxy statement.

## What to watch

Next: Q4 and full-year FY2026 results, Date not announced yet.

- **Book value and bond losses:** Book value per share was $30.73 at Sep 30, 2026, and accumulated other comprehensive loss was $25,304M. Each 10-Q shows the new figures.
- **The 2026 expense target:** On Feb 4, 2026, management set a 2026 target of 12.1% for the direct expense ratio (running costs as a share of premiums, fees and other revenues). The ratio was 11.9% in Q3 FY2026. The full-year figure comes with the Q4 FY2026 results.
- **Pension deal timing:** Pension risk transfer premiums arrive in large, uneven amounts: premiums were $16,691M in Q4 FY2025 against $10,555M in Q3 FY2025.
- **Chariot Re exposure:** MetLife had receivables of $11.9 billion related to Chariot Reinsurance, a related party, at Sep 30, 2026; the related-party note in each 10-Q updates the figure.

## Sources

- S1: Form 10-Q for Q3 FY2026. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1099219/000109921926000062/0001099219-26-000062-index.htm (published Nov 6, 2026)
- S2: Form 10-Q for Q2 FY2026. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1099219/000109921926000050/0001099219-26-000050-index.htm (published Aug 6, 2026)
- S3: Form 10-Q for Q1 FY2026. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1099219/000109921926000035/0001099219-26-000035-index.htm (published May 7, 2026)
- S4: Form 10-K for FY2025. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1099219/000109921926000013/0001099219-26-000013-index.htm (published Feb 19, 2026)
- S5: Form 10-Q for Q3 FY2025. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1099219/000109921925000230/0001099219-25-000230-index.htm (published Nov 7, 2025)
- S6: Form 10-Q for Q2 FY2025. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1099219/000109921925000193/0001099219-25-000193-index.htm (published Aug 7, 2025)
- S7: Form 10-Q for Q1 FY2025. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1099219/000109921925000135/0001099219-25-000135-index.htm (published May 1, 2025)
- S8: Form 10-K for FY2024. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1099219/000109921925000044/0001099219-25-000044-index.htm (published Feb 21, 2025)
- S9: Form 10-Q for Q3 FY2024. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1099219/000109921924000257/0001099219-24-000257-index.htm (published Nov 1, 2024)
- S10: Form 10-Q for Q2 FY2024. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1099219/000109921924000201/0001099219-24-000201-index.htm (published Aug 1, 2024)
- S11: Form 10-Q for Q1 FY2024. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1099219/000109921924000141/0001099219-24-000141-index.htm (published May 2, 2024)
- S12: Form 10-K for FY2023. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1099219/000109921924000035/0001099219-24-000035-index.htm (published Feb 16, 2024)
- S13: Form 10-K for FY2022. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1099219/000109921923000045/0001099219-23-000045-index.htm (published Feb 23, 2023)
- S14: Form 10-K for FY2021. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1099219/000109921922000014/0001099219-22-000014-index.htm (published Feb 18, 2022)
- S15: MetLife, Inc. 2026 proxy statement (DEF 14A). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1099219/000109921926000026/met-20260429.htm (published Apr 29, 2026)
- S16: MetLife, Inc. Q3 2026 earnings release (8-K Ex. 99.1). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1099219/000109921926000058/ex991earningsreleasetables.htm (published Nov 4, 2026)
- S17: MetLife, Inc. Q3 2026 quarterly financial supplement (8-K Ex. 99.2). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1099219/000109921926000058/ex992qfs8kdoc.htm (published Nov 4, 2026)
- S18: MetLife, Inc. Q4 2025 earnings release (8-K Ex. 99.1). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1099219/000109921926000008/ex991earningsreleasetables.htm (published Feb 4, 2026)
- S19: MetLife, Inc. Q4 2025 quarterly financial supplement (8-K Ex. 99.2). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1099219/000109921926000008/ex992qfsq425.htm (published Feb 4, 2026)
- S20: MetLife, Inc. Q4 2024 earnings release (8-K Ex. 99.1). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1099219/000109921925000039/ex991earningsreleasetables.htm (published Feb 5, 2025)
- S21: MetLife, Inc. Q4 2024 quarterly financial supplement (8-K Ex. 99.2). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1099219/000109921925000039/ex992qfsq424.htm (published Feb 5, 2025)
- S22: MetLife, Inc. Q2 2025 quarterly financial supplement (8-K Ex. 99.2). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1099219/000109921925000191/ex992qfsq225.htm (published Aug 6, 2025)
- S23: MetLife, Inc. Q3 2026 earnings call presentation (8-K Ex. 99.4). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1099219/000109921926000058/ex994earningscallpresent.htm (published Nov 4, 2026)
- S24: MetLife, Inc. Q4 2025 earnings call presentation (8-K Ex. 99.4). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1099219/000109921926000008/ex994q425earningscallpre.htm (published Feb 4, 2026)
- S25: MetLife, Inc. 8-K: amended and restated $4.0 billion credit agreement (Item 1.01). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1099219/000119312526454038/d155870d8k.htm (published Nov 10, 2026)
